Multiply Labs Robotic Biomanufacturing Platform

Robotic biomanufacturing clusters that automate biologics production inside closed GMP-ready environments, increasing throughput up to 100x at 74% lower cost.

multiplylabs.com

Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.

About

Multiply Labs develops modular robotic clusters that automate biologics manufacturing by connecting to a pharmaceutical customer's existing GMP instruments inside a closed, sterile environment using imitation learning, parallel orchestration, and real-time monitoring. The system increases throughput by up to 100x and reduces costs by 74% without requiring process transfer, and automates every unit operation with full 21 CFR Part 11-compliant electronic records delivered to quality systems in real time. The platform targets cell therapies, recombinant proteins, vaccines, and RNA therapies for pharma customers. Multiply Labs is based in San Francisco. Multiply Labs Robotic Biomanufacturing Platform is a product of Multiply Labs.

Added via
web
Ownership
unclaimed

Where to go

Product details

Product kind
Hardware
Pricing model
Enterprise
Free tier
No
Open source
No
Biologics manufacturing automationCell therapy production scalingGMP-compliant biomanufacturingPharmaceutical manufacturing cost reductionContamination risk reduction in cleanrooms